Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$11.97
-1.89%
Mkt Cap $279.31M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$47.00
Range $45.00 – $49.00
Implied Upside
+292.6%
Consensus $47.00 vs current $11.97
NASDAQ·Healthcare·Biotechnology
$11.97
-1.89%
Mkt Cap $279.31M
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$47.00
Range $45.00 – $49.00
+292.6%
Consensus $47.00 vs current $11.97